To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Remifentanil on Post-Operative Analgesic Consumption Following Shoulder Arthroplasty

Download
Share
Reprints
Cite This
About
+ Favorites
Download
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
October 2022

Remifentanil on Post-Operative Analgesic Consumption Following Shoulder Arthroplasty

Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Effect of remifentanil on post-operative analgesic consumption in patients undergoing shoulder arthroplasty after interscalene brachial plexus block: a randomized controlled trial

J Anesth . 2022 Aug;36(4):506-513.

Contributing Authors:
Y Kim H Bae S Yoo SK Park YJ Lim S Sakura JT Kim

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Sixty-eight patients undergoing arthroscopic repair for rotator cuff tears with an interscalene brachial plexus block were randomized to receive either remifentanil intraoperatively (n=34) or no analgesics intraoperatively (n=34). The primary outcome of this trial was the dose of fentanyl-nefopam IV-PCA postoperatively over 24 hours. Secondary outcomes such as the amount of rescue analgesics, tota...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.